Navigation Links
New Data Show That GlaxoSmithKline's Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
Date:9/19/2007

ines for Virus Diseases, GlaxoSmithKline Biologicals. "If the candidate vaccine is approved, infants could complete the rotavirus vaccine series by four months of age."

The CDC Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP) recommend that infants receive routine vaccination with the vaccine currently licensed by the FDA at two, four, and six months of age in order to prevent rotavirus gastroenteritis.

About the Rotarix(R) Co-Administration Study

This Phase III study was conducted to confirm that two doses of the rotavirus candidate vaccine do not impair the immune response to routine infant vaccines currently used in the U.S. In the study, 484 healthy infants ranging from six to 12 weeks of age were randomized (1:1) into two groups. One group received three doses of the currently recommended infant vaccines, Pediarix(R) (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Hepatitis B and Inactivated Poliovirus Vaccine), Prevnar(R) (Pneumococcal 7-valent Conjugate Vaccine) and ActHIB(R) (Haemophilus b Conjugate Vaccine), at two, four, and six months of age with the rotavirus candidate vaccine co-administered at two and four months of age (n=249). The second group received the rotavirus candidate vaccine administered separately at three and five months of age (n=235) as well as three doses of the currently recommended infant vaccines at two, four and six months of age.

Serum antibodies were measured one month after the third dose of routine vaccines (Pediarix, Prevnar and ActHIB). Antibody responses to routine vaccines were similar in both groups, indicating that the rotavirus candidate vaccine can be co-administered with other routine vaccinations without interfering with the immune response to any of the administered vaccines.

Results from the active phase of this study were included in GSK's Biologics License Application (BLA) for t
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
2. New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
3. New Cardioprotective Drug Could Provide Boost For Post-Bypass Surgery Heart Health
4. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
5. Over 10,000 UK Breast Cancer Patients Could Become Eligible Within the Next Year for a Breast Cancer Therapy Showing Increased Survival Rates, Reveals Synovate Healthcare’s European Oncology Monitor
6. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
7. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
8. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
9. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
10. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
11. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... --  iRhythm Technologies, Inc. , a leading digital healthcare solutions ... today that Banner Health, one of the largest nonprofit ... offering iRhythm,s ZIO ® Service to patients in ... Banner Health, we are dedicated to strengthening our patient ... John Hensing , MD, Banner Health,s executive vice president ...
(Date:4/21/2015)... 21, 2015  Decision Diagnostics Corp. (OTC PINK: ... exclusive worldwide sales, service and regulatory processes agent ... Alternative Strip, specifically designed to work with the ... family of glucose testing meters, the most popular ... Johnson & Johnson/Lifescan has requested an unscheduled Case ...
(Date:4/21/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today that 2015 first quarter financial results ... that day, the Company will hold a teleconference call ... discuss the results, followed by a question and answer ... and Chief Executive Officer of CryoLife, Inc. ...
Breaking Medicine Technology:Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 2Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 3Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 2Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 3CryoLife Announces Release Date and Teleconference Call Details for 2015 First Quarter Financial Results 2
... , , , , , ... PARIS and LAUSANNE, Switzerland ... innovation-driven global specialty,pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based ... of,prescription drugs that target unmet medical needs, announce the launch ...
... , THE WOODLANDS, Texas , Feb. 3 ... a biopharmaceutical company focused on discovering and developing breakthrough treatments for ... , Lexicon,s president and chief executive officer, will present at the ... on Monday, February 8, 2010 at 9:30 a.m., ...
Cached Medicine Technology:Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 2Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 3Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 4Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 5Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 6Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference 2Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference 3
(Date:4/21/2015)... (PRWEB) April 21, 2015 “ ZeroWire ... monthly Tech Report, which takes a look at the ... consumers. Scott Steinberg, a special reporter for NewsWatch and ... viewers how ZeroWire is a security system and lifestyle ... Investigation, there were over 2 million burglaries in 2010. ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 The joint ... today it is opening its first freestanding emergency room ... Chandler, Arizona and will be licensed under Dignity Health ... Dignity Health and Adeptus Health joint venture. , Tim ... and Mercy Gilbert Medical Centers said the new facility ...
(Date:4/21/2015)... Wireless Analytics, LLC , a pioneering ... the Boston Business Journal as the 25th fastest-growing private ... a recent event celebrating the 2015 Pacesetters, the ... companies in Massachusetts. , Wireless Analytics was ranked among ... the fastest revenue growth from 2011 through 2014. ...
(Date:4/21/2015)... April 21, 2015 The ... provides comparative analysis on the therapeutic development ... pipelines by identifying new targets and MOAs ... report with TOC is available @ ... reviews key players involved in the therapeutic ...
(Date:4/21/2015)... Riverside, CA (PRWEB) April 21, 2015 ... Programs, and Arthur “A.G.” Kawamura, former Secretary of the ... as featured speakers for the 2nd Annual GrowRIVERSIDE Conference: ... , The inclusion of these nationally known ... agriculture experts, city planners, farmers and others slated to ...
Breaking Medicine News(10 mins):Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 3
... May 13 The National Business Group on ... from some policymakers that would increase taxes on American ... represents 300 large employers - including 60 of the ... million Americans:"With our nation reeling from the worst economy ...
... Stephen T. Greenberg, a nationally known plastic surgeon, author ... and television personality is hosting a cosmetic surgery fashion ... surgery procedures. He will be speaking about hot topics ... fighter package and cosmetic surgery in a struggling economy.He ...
... to feature Best Hospitals in top categories and behind-the-scene highlights ... U.S. News and HealthiNation , ... video series featuring a selection of hospitals meeting the gold ... News ,s prestigious 2009 America,s Best Hospitals ...
... industry-established standards for all health data processing ... On-Line, a healthcare EDI company that processes ... today it has achieved full accreditation with ... the Electronic Healthcare Network Accreditation Commission (EHNAC). ...
... A potential vaccine for Alzheimer,s disease also has been ... associated with inclusion body myositis, a disorder that affects ... IBM patients with weakness, inflammation or atrophy of muscles ... no cure for IBM, nor is there an effective ...
... customers shop instant online coupons , sales and earn ... dollars(TM) programBELLEVUE, Wash., May 13 drugstore.com , inc. ... health, beauty, vision, and pharmacy products, is experiencing a dramatic ... the number of consumers visiting its coupon, sale and clearance ...
Cached Medicine News:Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 2Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 3Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 4Health News:MD On-Line, Inc. Receives EHNAC Healthcare Network Accreditation 2Health News:MD On-Line, Inc. Receives EHNAC Healthcare Network Accreditation 3Health News:Vaccine slows progression of skeletal muscle disorder 2Health News:Record Number of drugstore.com Customers Search for Bargains 2Health News:Record Number of drugstore.com Customers Search for Bargains 3Health News:Record Number of drugstore.com Customers Search for Bargains 4
The standard of proximal press-fit design. The CLS hip is a straight stem design that is available in 13 sizes in two different neck angles, 135 and 145, to accommodate a wide variety of patient anat...
The Perfecta IMC Stems, manufactured from forged cobalt- chrome, are specifically designed for cemented femoral stem arthroplasty....
Classic proven design with superior clinical results....
The Link SP II Hip stem for cemented revisions...
Medicine Products: